The Outermost Layer of the Body: The Semiotics of Skin

In the first chair of the dermatology clinic sits a 60-year-old carpenter. Beside his nasal ala is a small, shiny papule rimmed with fine telangiectasia, growing slowly for two years, its center occasionally crusting over and sloughing off. In the next room, a 32-year-old woman with type 2 diabetes says the skin of her upper back has suddenly grown as thick as a rubber mat — she can no longer even pinch up a fold of skin beneath her bra strap. In the next bed over, a child who took carbamazepine two weeks after a cold's fever subsided breaks out in erythema over the entire body, lips eroding, conjunctivae sloughing away — the physician on call takes one look and calls out: Stop the drug. Send to the ICU.

In all three faces, the skin is speaking on behalf of a different organ system. The first is basal cell carcinoma, gnawed out of the epidermal basal cells by years of ultraviolet exposure; the one in between is scleredema diabeticorum, in which chronic hyperglycemia deposits mucopolysaccharide in the dermis and hardens the skin; the last is SJS/TEN, in which T cells wipe out the full thickness of the epidermis. Dermatology questions on the licensing exam are hard not because you must memorize a thousand disease names, but because they demand that you work backward from a single lesion's morphology to an entire causal chain — get that chain right, and the diagnosis surfaces on its own.

This issue sets out from the three great cancers of the outermost epidermis, walks through the skin's role as a window onto systemic disease, the disorders of the pilosebaceous unit, the redness and blistering triggered by mast cells and T cells, and finally settles on genetic structure and the survival of the melanocyte. By the end, you will find that skin was never merely a covering — it is the body's dashboard, worn on the outside.

1. The Big Three of the Epidermis: The Slow Grower, the Ugly Grower, and the Deadliest Grower

🩺 At the bedside

The pearly papule beside the nasal ala has a slightly depressed center and a rim coiled with a few dilated capillaries; the carpenter says it has "looked like this for two years, hasn't grown much." The attending glances at it through a magnifier: "This is a BCC — basal cell carcinoma, the king of skin cancers, but don't worry, it's the least likely of all to metastasize." Next door, an old farmer has a keratotic nodule on his lower lip sitting atop a rough, scaly patch — that scaly patch is actinic keratosis, and the nodule has already progressed to SCC. In the room after that, a 45-year-old Taiwanese woman has noticed an unevenly pigmented, ragged-bordered dark streak beneath her big toenail, its color bleeding into the proximal nail fold — this Hutchinson sign drops the mood in the room instantly.

To make sense of the three great skin cancers, first pin down their cell of origin: basal cell carcinoma (BCC) arises from epidermal basal cells, squamous cell carcinoma (SCC) from keratinocytes, and melanoma from melanocytes. Once the origin is fixed, most of the behavior follows — basal cells are steady, keratinocytes are restless, and melanocytes are the boldest of all at wandering off.

Where Each of the Big Three Writes Its Character

🔬 Mechanism, unpacked

The "character" of the epidermal big three is really an extension of each cell's own role, and it unpacks into three complete causal chains:

① BCC: chronic ultraviolet exposure → PTCH1 mutation (loses its brake on SHH signaling) → dysregulated SHH (Sonic Hedgehog) signaling → basal cell overproliferation → local invasion that expands but almost never metastasizes to viscera — though given enough time it excavates a rodent ulcer (a central ulcer that looks as if gnawed by a rodent's teeth).

② SCC: ultraviolet light damages keratinocyte DNA → p53 mutations accumulate → this first becomes actinic keratosis (AK) → then progresses to SCC → and spreads along lymphatics (because its cell of origin, the keratinocyte, already knows how to keratinize and how to breach the basement membrane and burrow downward). So AK only ever heads toward SCC — it never becomes melanoma — the cell of origin decides that outright.

③ Melanoma: the melanocyte is a neural-crest descendant that already knows how to migrate → under ultraviolet exposure or genetic pressure (commonly BRAF V600E) → it first spreads horizontally, then grows vertically → it travels by both lymphatic and hematogenous routes, so even a tiny lesion can be lethal.

Feature	Basal Cell Carcinoma (BCC)	Squamous Cell Carcinoma (SCC)	Melanoma
Cell of origin	Epidermal basal cells	Keratinocytes	Melanocytes
Incidence	Most common skin cancer	Second most common	Less common but highest mortality
Typical appearance	Pearly papule, telangiectasia, central rodent ulcer	Keratotic nodule/ulcer, may progress from AK	Irregular pigmented lesion meeting ABCDE criteria
Metastasis	Almost never to viscera; good prognosis	May spread to regional lymph nodes	Readily metastasizes via blood and lymphatics
Precursor lesion	—	Actinic keratosis (progresses to SCC, not melanoma)	Dysplastic nevus

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

BCC is locally destructive but almost never metastasizes; melanoma can be tiny yet still be the deadliest. Reversing these two directions — metastasis and prognosis — is the single most common way points are lost on skin cancer questions.

The high-risk factors for BCC are likewise all about "whether it is likely to travel": morpheaform/infiltrative histologic subtype, perineural invasion, location in the H-zone (central face, ears, periocular area), poorly defined borders, and recurrent lesions. Meeting any single one of these is grounds to recommend Mohs micrographic surgery. Mohs is no romantic name — it exists because these lesions can creep silently along nerves, so the surgeon must confirm, layer by layer under the microscope, that the margins are clear before stopping.

Melanoma: ABCDE and the Soles of Taiwanese Feet

The mnemonic for early recognition of melanoma is ABCDE: Asymmetry, Border irregularity, Color variegation, Diameter > 6 mm, and Evolving over time. But this mnemonic is only a screen — what truly determines prognosis is Breslow thickness, the tumor's vertical depth: the thicker it is, the worse the prognosis, and ulceration and mitotic rate also factor into staging; Clark level (the anatomic depth of invasion) has since been relegated to secondary importance.

Histologic subtype	Features	Predilection
Superficial spreading	Most common (Western populations)	Trunk, extremities
Nodular	Vertical growth from the outset; poor prognosis	Any site
Lentigo maligna	Chronic sun exposure; older patients	Face
Acral lentiginous	Palms, soles, subungual	Most common in Taiwanese/Asian patients

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

The red flag for subungual melanoma is Hutchinson's sign: pigment extending onto the proximal nail fold — a sign that the lesion is no longer content to stay beneath the nail plate and has begun creeping outward. In advanced-stage treatment, about half of cutaneous melanomas carry a BRAF V600E mutation, making them treatable with BRAF plus MEK inhibitors; immune checkpoint inhibitors (anti-PD-1, anti-CTLA-4) have dramatically improved survival in advanced disease. But note one Taiwan-specific exam point: the acral lentiginous subtype has a lower BRAF mutation rate, so targeted-therapy data from Europe and North America cannot simply be transplanted onto Taiwanese patients.

Benign and Precancerous: Don't Mistake a Port-Wine Stain for a Cancer

Condition	Nature	Key points/numbers
Sturge-Weber port-wine stain	Benign vascular malformation, not a malignant tumor	Distributed along trigeminal V1; associated with leptomeningeal angioma, glaucoma, seizures
Actinic keratosis	Precancerous lesion	Progresses to SCC (not melanoma)
Keratoacanthoma	Low malignant potential/may spontaneously regress	Rapid growth over weeks on the face; crater-shaped keratotic nodule; histology resembles SCC
NF-1 (autosomal dominant)	Autosomal dominant	Café-au-lait spots > 5 mm before puberty, > 15 mm after puberty (meeting the threshold count is one diagnostic criterion)

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

The numbers for NF-1 are a favorite target for reversal: 5 mm and 15 mm are the two thresholds, not 30 mm. The trap answer choices love to rewrite the threshold as 3 mm or 30 mm.

⭐ Board-exam essentials

The Epidermal Big Three · Precancerous and Benign Lesions

BCC = most common, almost never metastasizes to viscera, best prognosis; high risk (morpheaform, perineural invasion, H-zone, recurrent) → Mohs surgery.
AK progresses to SCC (not melanoma); SCC spreads via regional lymphatics.
Melanoma prognosis is determined first by Breslow thickness; BRAF V600E-positive tumors can be treated with BRAF+MEK inhibitors; the most common subtype in Taiwan = acral lentiginous (lower BRAF mutation rate).
Hutchinson's sign = subungual pigment extending onto the proximal nail fold, a red flag for subungual melanoma.
Port-wine stain = benign vascular malformation, not a tumor; Sturge-Weber is associated with leptomeningeal angioma, glaucoma, and seizures.
Keratoacanthoma = rapid growth over weeks on the face, crater-shaped; histology resembles SCC but behavior leans benign.
NF-1 café-au-lait spots: > 5 mm in children, > 15 mm in adults (not 30 mm).
Traps: describing BCC as "readily metastatic," describing melanoma as "good prognosis," saying AK turns into melanoma, listing port-wine stain among malignant tumors, rewriting the NF-1 threshold as 30 mm, and assuming acral melanoma always carries a BRAF mutation — all are common exam-killers.

♪ Sing-along text — English rendering of the Mandarin song lyrics

🎵 Chapter song　皮膚・表皮三巨頭Spotify Apple Music

Alternate take (Version B): Spotify · Apple Music

Sung in Mandarin by Otter Whistle · album 《醫學國考・皮膚》 · the text below is an English rendering of the lyrics

Into the dermatology clinic sits a sixty-year-old carpenter with a small, shiny papule beside his nasal ala, rimmed with fine telangiectasia, growing slowly for two years, its center occasionally crusting and sloughing — the signature look of basal cell carcinoma. Next door, an old farmer has a keratotic nodule on his lower lip sitting atop a rough, scaly patch; that patch is the precancerous lesion actinic keratosis, and the nodule has already progressed to squamous cell carcinoma. In the next bed, a middle-aged woman has a streak of unevenly pigmented, ragged-bordered darkness beneath her big toenail, its color bleeding into the proximal nail fold — the moment this Hutchinson sign appears, the mood drops instantly, because it is almost certainly subungual melanoma knocking at the door.

Character is written into origin: basal cells dawdle, squamous cells run for the lymph nodes, melanocytes light out for parts unknown.

The questions on the three great skin cancers really only require fixing the cell of origin first, and the behavior all follows from that. Basal cells have always been the quiet dividers sitting at the very bottom of the epidermis, so the tumors that arise from them are likewise steady and slow — basal cell carcinoma almost never metastasizes to the viscera, and merely excavates, in place, a central ulcer that looks as though a rodent has gnawed it. But if it arises in the H-zone — central face, ears, periocular area — or its histologic subtype is morpheaform or infiltrative, or it has already crept silently along a nerve, then this recurrence-prone, poorly demarcated variant calls for Mohs micrographic surgery, confirming every layer clean under the microscope before stopping. Keratinocytes are the cells whose DNA gets damaged by ultraviolet light, so the forerunner of squamous cell carcinoma is actinic keratosis; this shared origin also explains a direction-reversal question the exam loves to play: actinic keratosis turns into squamous cell carcinoma, not into melanoma, because the cell of origin is the keratinocyte. Reversing this direction is a pit that trips up nearly everyone in the exam hall.

Character is written into origin: basal cells dawdle, squamous cells run for the lymph nodes, melanocytes light out for parts unknown.

Melanocytes are, by nature, neural-crest descendants born to migrate, so once they turn malignant they travel by both lymphatic and hematogenous routes, and a lesion can be tiny and still lethal. Early screening uses ABCDE — asymmetry, irregular border, mixed color, diameter over six millimeters, evolving over time — but what truly decides prognosis is the tumor's vertical thickness: the thicker it is, the worse the prognosis, and ulceration and mitotic rate also count toward staging, while the older Clark scale, which measured how deep the invasion reached, has since been crowded out to secondary importance. Taiwan and the West differ here in a critically important way: in people of European descent, the most common subtype is superficial spreading, arising on the sun-exposed trunk and limbs; but in East Asia and Taiwan, the most common is instead acral lentiginous melanoma, arising on the palms, soles, and beneath the nails — sites that never see the sun. So that dark streak beneath a toenail must never be dismissed as a stubbed-toe bruise; if the pigment also extends onto the proximal nail fold, that is Hutchinson's sign, and it should raise alarm for subungual melanoma. In advanced-stage treatment, roughly half of cutaneous melanomas carry a BRAF V600E mutation and can be treated with BRAF plus MEK inhibitors; immune checkpoint inhibitors have also dramatically improved survival in advanced disease. But there is one Taiwan-specific exam point: the acral subtype has a lower rate of BRAF mutation, so targeted-therapy data from Europe and North America cannot simply be transplanted onto Taiwanese patients.

As for the remaining benign and precancerous lesions, the traps mostly lie in "directional words." A crater-shaped nodule with a central keratin plug that grows on the face within a few weeks — its histology may look like squamous cell carcinoma, but its speed is the real clue: this is a keratoacanthoma, which may regress spontaneously; excision for confirmation is still advisable, of course, but don't judge it as highly malignant and go straight to radical excision on first sight. A dark red patch present since birth, distributed along the V1 branch of the trigeminal nerve, is a port-wine stain — a benign vascular malformation, not a tumor — though it warrants follow-up for ipsilateral leptomeningeal angioma, glaucoma, and seizures; this Sturge-Weber syndrome is most often wrongly filed under the malignant list as a reversed-direction question. The café-au-lait spots of neurofibromatosis type 1 have thresholds of five millimeters in children and fifteen millimeters in adults, not thirty millimeters — this number, too, is tested year after year.

Character is written into origin: basal cells dawdle, squamous cells run for the lymph nodes, melanocytes light out for parts unknown.

2. Skin as a Window on the Body: From a Single Plaque to an Entire System

The skin does not only grow diseases of its own — it is often the indicator light for disease elsewhere in the body. The exam's classic sentence structure is: one pictured lesion + one systemic clue (chronic diabetes, a granulomatous chest film, a history of sexual contact, a post-infectious erythema) — asking you to match them up. But the real skill is not rote pairing; it is asking of every skin clue, "why did it grow this way" — once you know that asymptomatic thickening and induration almost always means something is accumulating in the dermis, that itching with weeping mostly means the epidermal cells are swelling with edema, and that bilateral hilar lymphadenopathy is the intrathoracic echo of a non-caseating granuloma, the line running from a skin finding to a systemic diagnosis will connect itself.

Learn to "Describe" First, Then Talk "Differential"

Primary lesion	Definition	Typical example
Macule / Patch	Flat pigment or erythema change, not palpable	Vitiligo, café-au-lait spot
Papule / Plaque	Raised, <1 cm / >1 cm	Psoriatic plaque, lichen planus
Nodule	Solid dermal or subcutaneous mass	Granuloma, metastatic carcinoma
Vesicle / Bulla	Fluid-filled, <0.5 cm / >0.5 cm	Pemphigus, pemphigoid
Wheal	Transient dermal edema	Urticaria

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

Only if you can describe it can you differentiate it. An "asymptomatic, thickened, indurated plaque" should point you toward deposition/fibrosis; a "granulomatous nodule" should point you toward sarcoidosis, tuberculosis, or deep fungal infection. Get the morphologic terms right, and the differential is already half as wide.

Sarcoidosis: Skin Plus Bilateral Hilar Adenopathy

The most specific cutaneous manifestation is lupus pernio — violaceous infiltrated plaques on the nose, cheeks, and ears; granulomatous infiltration of old scars is also common. Löfgren syndrome is the acute triad of bilateral hilar adenopathy plus erythema nodosum plus arthritis, and it carries a good prognosis.

Scleredema Diabeticorum: A Rubber Mat Across the Upper Back

Distinguishing feature	Scleredema diabeticorum	Scleroderma
Site of onset	Central trunk (upper back, nape, shoulders)	Acral (fingers)
Raynaud phenomenon	Absent	Present
Autoantibodies	Negative	Positive (anti-Scl-70, anticentromere)
Association	Type 2 diabetes, obesity, poor glycemic control	Connective tissue disease

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

Another frequently tested cutaneous manifestation of diabetes is necrobiosis lipoidica — a yellow-brown atrophic plaque on the pretibial skin — occupying a completely different site and having an entirely different texture from scleredema. The word "asymptomatic" should always put you on alert — it usually signals a deposition-related or metabolic lesion rather than an inflammatory one (eczema, by contrast, itches).

A Cheat Sheet for the Skin of Systemic Disease

The table below is not a "lookup chart" meant to be memorized up front — it is a quick-reference summary meant to be scanned after you have worked through every causal chain above.

Skin clue	Points to	Underlying mechanism
Bilateral hilar lymphadenopathy + granuloma	Sarcoidosis	Non-caseating granuloma; ACE↑, hypercalcemia
Symmetric asymptomatic induration of the upper back + diabetes + obesity	Scleredema diabeticorum	Dermal mucin deposition + collagen glycation
Yellow-brown atrophic pretibial plaque	Necrobiosis lipoidica (diabetes)	Dermal collagen degeneration
Velvety hyperpigmented thickening of the neck/axilla	Acanthosis nigricans	Insulin resistance / visceral malignancy (if sudden onset)
Sudden eruption of numerous seborrheic keratoses (Leser-Trélat sign)	Visceral malignancy	Paraneoplastic phenomenon
Malar erythema, photosensitivity	SLE	Immune complexes + photosensitivity

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

Eczema and Psoriasis: Red and Scaly, but Opposite Mechanisms

🔬 Mechanism, unpacked

Psoriasis takes an entirely different path:

① genetic susceptibility (HLA-Cw6) plus a triggering trauma or infection → ② dendritic cells activate the IL-23 axis, driving out Th17 cells → ③ IL-17, IL-23, and TNF-α drive keratinocyte overproliferation → ④ epidermal turnover accelerates from a normal 28 days to 3–4 days, so keratinocytes are pushed to the surface before they have matured → ⑤ this piles up dry, silvery-white, thick scale (parakeratosis — retained nuclei in the stratum corneum) and Munro microabscesses. It favors extensor surfaces (the extensor elbows and knees, scalp, and sacrum), is sharply demarcated, and is relatively less itchy. Scraping the scale produces pinpoint bleeding — this is the Auspitz sign (exposure of the dermal papillary capillaries); new lesions arising at sites of scratching or trauma is the Koebner phenomenon; the nails show pitting, like a thimble, and an oil-drop sign. It is often associated with psoriatic arthritis, metabolic syndrome, and elevated cardiovascular risk.

Feature	Eczema (atopic)	Psoriasis
Pathology	Spongiosis (spongy edema)	Epidermal hyperplasia, parakeratosis, Munro microabscesses
Scale	Fine, greasy, weeping	Dry, silvery-white, thick
Distribution	Flexor surfaces (antecubital/popliteal fossae)	Extensor surfaces (elbows/knees), scalp, sacrum
Border	Poorly defined	Sharply defined
Itch	Intense	Relatively mild
Blood findings	Eosinophils↑, IgE↑	—

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

The psoriasis treatment ladder: topical therapy (corticosteroids plus the vitamin D analog calcipotriol) → phototherapy (NB-UVB) → systemic agents (MTX, cyclosporine, acitretin) → biologics (anti-TNF, anti-IL-17 / anti-IL-23). One life-threatening trap: abrupt withdrawal of systemic corticosteroids can trigger pustular psoriasis, so psoriasis generally avoids oral corticosteroids; beta-blockers, lithium, and antimalarials can also trigger or worsen it.

Stasis and Winter: Two Tales of the Lower Leg

Two conditions of the lower leg — "pigment change plus scaling" — are most often tested: stasis dermatitis arises on the lower third of the leg and medial ankle because of venous hypertension/varicose veins, venous pooling, and skin pigmentation (from deposited hemosiderin); it is warm and edematous. The trap is to mislabel it as peripheral artery occlusive disease (PAOD) — but PAOD is pale, cold, hairless, and painful, exactly the opposite picture. Asteatotic (winter) eczema, by contrast, is the dry, cracked "crazy-paving" pattern — eczema craquelé — that appears on elderly patients' shins in winter; its core management is moisturization and reduced irritation, avoiding hot water, soap, and excessive bathing.

Do	Don't
Brief lukewarm baths, apply emollient immediately afterward	Excessive bathing, hot water/soap
Indoor humidification, cotton clothing	Vigorous scratching, frequent exfoliation
Short-term topical corticosteroids to control acute inflammation	Prolonged potent corticosteroids on thin skin

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

⭐ Board-exam essentials

Skin as a Systemic Window · Must-Know Checklist

Sarcoidosis = cutaneous granuloma + bilateral hilar adenopathy; ACE↑, hypercalcemia/hypercalciuria; the Löfgren triad has a good prognosis; erythema nodosum is an accompanying feature, not histologically a granuloma.
Scleredema diabeticorum: symmetric, asymptomatic induration of the upper back / nape / shoulders, with obesity plus poorly controlled T2DM; begins centrally on the trunk, no Raynaud phenomenon, no autoantibodies (contrast scleroderma, which begins acrally).
Necrobiosis lipoidica = yellow-brown atrophic pretibial plaque (diabetes); acanthosis nigricans = insulin resistance / visceral malignancy (if sudden onset).
Atopic dermatitis = Th2, eosinophils↑, IgE↑, flexor surfaces, filaggrin barrier defect; it is eosinophils that rise (not neutrophils); new treatment dupilumab (anti-IL-4Rα).
Psoriasis = Th17/IL-23, extensor surfaces, thick silvery scale, Auspitz sign, Koebner phenomenon, nail pitting; avoid oral corticosteroids (abrupt withdrawal → pustular psoriasis); beta-blockers, lithium, and antimalarials can trigger it.
Pityriasis alba: hypopigmented, finely scaling patches on the face of atopic children, benign, improves with age.
Lower-leg pigment change + varicose veins = stasis dermatitis (venous), not PAOD (arterial).
Asteatotic eczema management: moisturizer is king; avoid hot water/soap/excessive bathing (the "least appropriate" answer choice is usually "soak in a hot bath").
Traps: treating erythema nodosum as sarcoidosis's granulomatous lesion itself (it is only an accompanying feature); reversing the flexor/extensor distribution of eczema and psoriasis; writing the elevated cell type in atopic dermatitis as neutrophils; giving psoriasis oral corticosteroids that rebound into the pustular form on withdrawal; describing scleredema as beginning acrally (that is scleroderma).

♪ Sing-along text — English rendering of the Mandarin song lyrics

🎵 Chapter song　皮膚・皮膚是身體的窗口Spotify Apple Music

Alternate take (Version B): Spotify · Apple Music

Sung in Mandarin by Otter Whistle · album 《醫學國考・皮膚》 · the text below is an English rendering of the lyrics

Three people sit down in the clinic one after another, and in each the skin is speaking for a different organ system. The first is a thirty-two-year-old woman with diabetes whose upper back has grown tighter and tighter, like a rubber mat laid over it, so that she can no longer even pinch up a fold under her bra strap — this induration is telling you that mucopolysaccharide is accumulating in her dermis, that chronic hyperglycemia has glycated her collagen, and that this is scleredema diabeticorum. The second is a twenty-nine-year-old woman with violaceous infiltrated plaques on her nose, cheeks, and ears, her chest film reading bilateral hilar lymphadenopathy — this cluster of granulomas in her skin and the enlarged lymph nodes in her chest are the same story, called sarcoidosis. The third is a four-year-old boy with intensely itchy, poorly demarcated erythema in the antecubital and popliteal fossae, his blood showing both eosinophils and IgE elevated — this spongy edema in his skin is telling you that he is an atopic child, and the diagnosis is atopic dermatitis. Skin does not only grow diseases of its own; it is often the indicator light for disease elsewhere in the body.

Read the skin on two levels: spongiosis in the epidermis means eczema that weeps; a buildup in the dermis means hardening without symptoms.

To make sense of this matching game, don't treat it as rote memorization. First build the habit of description: keep macule distinct from papule, papule from plaque, nodule from vesicle, and transient edema distinct from all of them, and the differential is already half as narrow. When a question gives you an asymptomatic, thickened, indurated plaque, think deposition and fibrosis; when it gives you a granulomatous nodule, think sarcoidosis, tuberculosis, and deep fungal infection; when it gives you an itchy, weeping red rash, think of the spongiosis family. The core of sarcoidosis is the non-caseating granuloma: macrophages and T cells cluster together but never develop the central caseation seen in tuberculosis; this cluster of granulomas can arise in any organ but favors the mediastinum and the skin, so the most frequently tested link is that cutaneous granuloma plus bilateral hilar adenopathy equals sarcoidosis. Its serum fingerprint is an elevated angiotensin-converting enzyme along with elevated serum and urinary calcium, for a delightfully specific reason: those activated macrophages manufacture their own active vitamin D and push the calcium upward. Löfgren syndrome is the acute triad of bilateral hilar adenopathy, erythema nodosum, and arthritis, and it carries a good prognosis — but watch for one directional trap: erythema nodosum is itself a reactive panniculitis, not a granuloma histologically; it is sarcoidosis's neighbor, not the lesion itself.

Scleredema diabeticorum likewise makes sense once you think the same causal chain through. Chronic hyperglycemia glycates the dermal collagen, mucin piles in on top of it, and the skin turns into a symmetric, asymptomatic induration that, of all places, begins at the central trunk — the upper back, nape, and shoulders — the exact opposite of scleroderma, which begins at the fingertips and comes with Raynaud phenomenon and autoantibodies. This directional question is one of the exam's favorite differentials. Another cutaneous manifestation of diabetes is the yellow-brown atrophic pretibial plaque called necrobiosis lipoidica, which differs from scleredema in both location and texture — don't confuse the two. Whenever you see the word "asymptomatic," raise your guard, because asymptomatic usually signals a deposition-related or metabolic process rather than an inflammatory one, since eczema itches and inflammation hurts.

Read the skin on two levels: spongiosis in the epidermis means eczema that weeps; a buildup in the dermis means hardening without symptoms.

The pair most easily confused within the red-and-scaly family is eczema and psoriasis. The pathologic core of eczema is edema between epidermal cells: fluid seeps in between the cells like a sponge being forced open by water, so it weeps and it itches. Atopic dermatitis follows exactly this Th2-dominant path — IL-4, -5, and -13 drive up both IgE and eosinophils — and with the barrier gene filaggrin defective, moisture cannot be held in and allergens penetrate easily, so lesions concentrate on the flexor surfaces such as the antecubital and popliteal fossae, are intensely itchy, and relapse chronically. A Th1 and Th17 component blends in during the chronic phase, but the core memory remains Th2, which is why the new drug dupilumab blocks precisely the IL-4 receptor alpha. Keep in mind one point that is easily reversed on the exam: it is eosinophils, not neutrophils, that rise in atopic dermatitis, and an elevated serum IgE is not itself a diagnostic criterion. This also leads into the atopic march: infants first develop atopic dermatitis, and then, in sequence, food allergy, asthma, and allergic rhinitis follow, all sharing the same underlying Th2 and IgE-driven constitution.

Psoriasis takes an entirely different route: T cells drive keratinocyte overproliferation through IL-17, IL-23, and TNF, accelerating epidermal turnover from a normal twenty-eight days down to three or four, so keratinocytes are pushed to the surface before they have matured, piling up dry, silvery-white, thick scale. It carries the familial HLA-Cw6 association, favors the extensor surfaces, scalp, and sacrum, and is sharply demarcated and relatively less itchy. Pinpoint bleeding on scraping the scale is the Auspitz sign, caused by exposure of the dermal papillary capillaries; new lesions arising at sites of scratching or trauma are the Koebner phenomenon; the nails show pitting, like a thimble, and an oil-drop sign. It is associated with psoriatic arthritis, metabolic syndrome, and elevated cardiovascular risk. The treatment ladder runs from topical therapy plus the vitamin D analog calcipotriol, through phototherapy, to systemic methotrexate or cyclosporine or acitretin, and finally to biologics targeting TNF, IL-17, or IL-23. The most dangerous trap is never to control psoriasis with systemic corticosteroids, because abrupt withdrawal rebounds into the pustular form; beta-blockers, lithium, and antimalarials can also trigger or worsen it. Describing eczema as dry with thick silvery scale, describing psoriasis as weeping and intensely itchy, or reversing the flexor and extensor distributions are the most common ways points are lost in this family.

Read the skin on two levels: spongiosis in the epidermis means eczema that weeps; a buildup in the dermis means hardening without symptoms.

The lower leg holds two more small tales. Stasis dermatitis arises on the lower third of the leg and the medial ankle, because venous hypertension causes blood to pool, the skin to pigment, and the area to feel warm with edema — the exact opposite direction from peripheral artery occlusive disease, which is pale, cold, hairless, and painful. Asteatotic winter eczema, by contrast, is the crazy-paving cracking that appears on elderly patients' shins in winter; management is moisturization — brief lukewarm baths followed immediately by emollient application, avoiding hot water, soap, and excessive bathing — so the answer to a "which is least appropriate" question is usually "soaking in frequent hot baths" or "liberal soap use." The whole chapter strings together into a single sentence: skin never speaks alone — either the epidermis is swelling with edema, or the dermis is accumulating something; look at the level first, then connect it to the system, and the matching game will link itself up.

3. Disorders of the Pilosebaceous Unit: From Acne to Baldness and Hidradenitis

🩺 At the bedside

A high school senior walks into the clinic wearing a mask; the moment he pulls it down, his chin and both cheeks are covered in red, swollen nodulocystic lesions, several of them draining pus at the center, with dark acne scars beneath his jaw. He has had this since the second year of junior high, has tried topical medications and oral antibiotics, and it relapses every time he stops. His mother chimes in: "Can he get that legendary drug that supposedly cures it for good? But I heard it causes birth defects — can he really take it?" In the next room, a 28-year-old woman complains of "recurrent axillary abscesses for two years, which I thought were a lymph node infection" — but every time antibiotics clear one, another pops up right beside it, leaving behind dark indurated nodules and sinus tracts.

Diseases of the pilosebaceous unit come down to just three core problems: sebum secretion and keratinization (acne), follicular miniaturization (androgenetic alopecia), and follicular occlusion with inflammation (hidradenitis suppurativa).

Acne's Four Hands and the Drug Ladder

🔬 Mechanism, unpacked

Acne vulgaris has four hands pressing at once, and they string into a single causal chain:

① androgens stimulate the sebaceous gland → sebum secretion↑ → ② abnormal follicular keratinization → the pore plugs to form a comedone → ③ the environment beneath the comedone turns anaerobic, and Cutibacterium acnes proliferates → sebum is broken down into free fatty acids and pro-inflammatory mediators → ④ a dermal inflammatory response ignites, and the comedone progresses into a papule, pustule, or nodulocystic lesion.

Treatment is a "combination punch" precisely because it must answer each of these four hands, striking down one at a time — which is exactly why using an antibiotic alone hits only the third step, leaving the other three free to keep causing trouble, giving poor results while breeding resistance.

Mechanism	Corresponding drug
① Sebum secretion↑	Isotretinoin, antiandrogens
② Abnormal follicular keratinization	Topical retinoid (comedolytic)
③ C. acnes proliferation	Antibiotics (oral doxycycline, topical)
④ Inflammatory response	Benzoyl peroxide, anti-inflammatory agents

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

Severity	First-line therapy
Mild (comedonal)	Topical retinoid ± benzoyl peroxide
Moderate (papulopustular)	+ topical/oral antibiotic; avoid antibiotic monotherapy (prone to resistance)
Severe (nodulocystic, scarring)	Oral isotretinoin

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

Oral isotretinoin is currently the only drug that can produce long-term remission of acne — it shrinks the sebaceous glands and suppresses both sebum production and keratinization, shutting down acne's factory at its source. But the cost is this: it is a potent teratogen, and pregnancy is an absolute contraindication.

The exam points for oral isotretinoin (13-cis-retinoic acid) all concern its cost:

Absolute contraindication = pregnancy, which can cause craniofacial, cardiac, and central nervous system malformations; strict contraception and pregnancy testing are required before and during treatment (the iPLEDGE concept).
Adverse effects: cheilitis and mucocutaneous dryness (most common), elevated triglycerides, elevated liver enzymes — these require monitoring.
Contraindicated in combination with tetracycline — both drugs raise intracranial pressure, and combining them can precipitate pseudotumor cerebri (idiopathic intracranial hypertension).

🦦

PipThis senior's acne is so severe — I'll just put him on long-term oral antibiotics, right? Keep prescribing it for six months straight, since he can't get pregnant anyway!

🐻‍❄️

BarnabyThat single prescription falls into two pits at once. Long-term antibiotic monotherapy breeds antibiotic-resistant C. acnes, so it works worse and worse over time — which is why the treatment ladder requires an antibiotic to always be paired with benzoyl peroxide or a retinoid. And his severe nodulocystic disease should be escalated to isotretinoin — pregnancy is an absolute contraindication, sure, but he's male, so as long as you monitor his mucous membranes, lipids, and liver function, and avoid combining it with tetracycline (or risk pseudotumor cerebri), that is the textbook answer for this case.

Androgenetic Alopecia: Not "Falling Out More," but "Growing Thinner"

Differential	Androgenetic alopecia	Alopecia areata	Telogen effluvium
Onset	Gradual, follicular miniaturization	Sudden, sharply demarcated round patches	Diffuse, 2–3 months after childbirth/stress
Nature	Non-scarring	Autoimmune	Temporary
Red flag	M-shaped hairline, crown thinning	Exclamation-point hairs	Diffuse shedding across the whole scalp

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

Treatment for androgenetic alopecia: topical minoxidil (prolongs the growth phase) plus oral finasteride (a 5α-reductase inhibitor that lowers DHT; contraindicated in pregnant women).

Hidradenitis Suppurativa (HS): Fundamentally Not an Infection

🔬 Mechanism, unpacked

The name hidradenitis suppurativa (HS) is easy to misread — "suppurativa," "hidraden(o)-" (sweat gland), and "-itis" all sound like an infectious disease. The actual causal chain:

① follicles in apocrine-gland-bearing areas first become abnormally keratinized and occluded → ② follicular contents and a keratin plug build up, bursting the follicle and spilling into the dermis → ③ the dermis mounts chronic inflammation against this foreign mass, driven by IL-17 and TNF-α → ④ painful nodules, abscesses, sinus tracts, and scars form → ⑤ antibiotics only strike the downstream, secondary bacteria and cannot undo the upstream occlusion, so new lesions keep erupting.

This chain also explains why treatment must turn to immunosuppression and biologics (adalimumab, an anti-TNF-α agent; secukinumab, an anti-IL-17 agent), rather than relying on antibiotics alone.

Predilection: female > male, after puberty; apocrine-gland-bearing areas — axillae, groin, perineum, inframammary folds.
Risk factors: obesity, smoking, family history.
Treatment ladder: topical/oral antibiotics (clindamycin plus rifampin) → immunosuppression/anti-inflammatory therapy (because it is inflammatory, not infectious) → biologics: anti-TNF-α (adalimumab) was the first biologic approved (2015) for moderate-to-severe HS, and it remains the standard exam answer; in recent years anti-IL-17 agents (secukinumab, bimekizumab) have also been approved → severe sinus tracts/scarring require surgical excision.

Hirsutism vs. Hypertrichosis: Definitions That Must Not Be Swapped

⭐ Board-exam essentials

The Pilosebaceous Unit · Must-Know Checklist

Oral isotretinoin's absolute contraindication = pregnancy (a potent teratogen); adverse effects mucosal dryness, elevated triglycerides, elevated liver enzymes; contraindicated with tetracycline (pseudotumor cerebri).
Acne should never be treated with oral antibiotic monotherapy (prone to resistance); it must be paired with benzoyl peroxide / a retinoid.
Androgenetic alopecia = DHT-driven follicular miniaturization, gradual, non-scarring; not "sudden, massive shedding"; treated with minoxidil + finasteride.
Hidradenitis suppurativa (HS) is fundamentally = follicular occlusion, not a simple bacterial infection; female > male, favors apocrine-bearing areas; adalimumab (anti-TNF-α) was the first approved biologic.
Hirsutism (androgen-related, androgen-dependent sites in women) ≠ hypertrichosis (androgen-unrelated, any site); swapping the two is a common trap.
Traps: combining isotretinoin with tetracycline, precipitating pseudotumor cerebri; treating acne with oral antibiotic monotherapy and breeding resistance; describing androgenetic alopecia as "sudden, massive shedding" (that is telogen effluvium); treating HS as a simple bacterial infection with prolonged antibiotics; swapping the definitions of hirsutism and hypertrichosis.

♪ Sing-along text — English rendering of the Mandarin song lyrics

🎵 Chapter song　皮膚・毛囊皮脂腺的失序Spotify Apple Music

Alternate take (Version B): Spotify · Apple Music

Sung in Mandarin by Otter Whistle · album 《醫學國考・皮膚》 · the text below is an English rendering of the lyrics

The moment the high school senior pulls down his mask, his chin and cheeks are a mass of red, swollen nodulocystic lesions plus pigmented scarring, and his mother anxiously asks whether he can use that legendary drug that supposedly cures it for good but causes birth defects. In the next room, a twenty-eight-year-old woman complains of recurrent axillary abscesses for two years — antibiotics knock out one, and another pops up right beside it, leaving sinus tracts and indurated nodules behind. Both of these people have something wrong with their pilosebaceous unit, but they are on completely different paths.

The pilosebaceous unit has only three plots: sebum and keratin turn into acne, a shrinking follicle turns into baldness, a sealed follicle turns into abscess.

The core of acne is four hands pressing at once: androgens force the sebaceous gland to secrete more oil, abnormal follicular keratinization plugs the pore into a comedone, the anaerobic bacterium Cutibacterium acnes living in the sebum breaks that oil down into inflammatory mediators, and the inflammatory response then pushes the comedone forward into a papule, pustule, or nodulocystic lesion. Treatment must therefore answer each of the four hands with a strike of its own: topical retinoic acid dissolves comedones, benzoyl peroxide is both antibacterial and anti-inflammatory, an oral antibiotic such as doxycycline treats the bacteria, and in severe cases oral retinoic acid shrinks the sebaceous gland itself. The ladder runs from topical therapy alone for mild disease, to adding a topical or oral antibiotic for moderate disease — never as antibiotic monotherapy, to avoid resistance — up to oral retinoic acid for severe nodulocystic disease. This oral retinoic acid is currently the only drug that produces long-term remission of acne, because it shrinks the sebaceous gland at the source, but the cost is that it is a potent teratogen: pregnancy is an absolute contraindication, strict contraception and pregnancy testing are required before and during treatment, and women of childbearing age are enrolled in monitoring like the iPLEDGE program. The most common side effects are cheilitis and mucosal dryness, along with elevated triglycerides and elevated liver enzymes, which require monitoring — and it must never be combined with tetracycline, because both drugs raise intracranial pressure, and combining them can precipitate pseudotumor cerebri, that is, benign intracranial hypertension.

The pilosebaceous unit has only three plots: sebum and keratin turn into acne, a shrinking follicle turns into baldness, a sealed follicle turns into abscess.

The biggest directional trap in androgenetic alopecia is never to describe it as sudden, massive shedding. Its key feature is a genetically susceptible follicle that, under the action of testosterone converted by 5α-reductase into DHT, gradually miniaturizes — the follicle is still there, just growing thinner and thinner with an ever-shorter growth phase, so it looks sparse and fine rather than falling out in fistfuls. It is gradual and non-scarring. If a question presents it as "acute hair loss," that description is wrong; that kind of sudden, diffuse shedding should point you to stress or the telogen effluvium of two to three months postpartum, while sharply demarcated round patches plus exclamation-point hairs should point you to alopecia areata, an autoimmune form of baldness. Treatment is topical minoxidil to prolong the growth phase and oral finasteride to inhibit 5α-reductase and lower DHT, though it is contraindicated in pregnant women.

The essential nature of hidradenitis suppurativa is frequently misunderstood. Its English name sounds like an infectious disease, but the follicle first occludes, then bursts and spills into the dermis, and the dermis mounts chronic inflammation — the pus is a result of inflammation, not the cause of infection, so plain antibiotics only strike the downstream bacteria and cannot undo the upstream occlusion, which is why new lesions keep erupting. It favors women over men, after puberty, in the apocrine-gland-bearing axillae, groin, perineum, and inframammary folds, with risk factors of obesity, smoking, and family history. The treatment ladder begins with topical and oral antibiotics such as clindamycin paired with rifampin; moderate-to-severe disease, being inflammatory rather than infectious, can be treated with immunosuppression, and the first-choice biologic is adalimumab, an anti-TNF-alpha agent that was first approved in 2015 and remains the standard exam answer; in recent years, the anti-IL-17 agents secukinumab and bimekizumab have also been approved, reflecting IL-17's role in this disease, though exam questions still center on adalimumab. Severe sinus tracts and scarring require surgical excision.

The pilosebaceous unit has only three plots: sebum and keratin turn into acne, a shrinking follicle turns into baldness, a sealed follicle turns into abscess.

The last small distinction worth sorting out is the definitional difference between hirsutism and hypertrichosis. Hirsutism is male-pattern hair growth, describing coarse dark hair appearing on a woman in androgen-dependent sites such as the upper lip, chin, chest, and midline abdomen, driven by androgen excess, commonly from polycystic ovary syndrome or an adrenal problem. Hypertrichosis is excess hair growth regardless of sex, not confined to any site, and unrelated to androgens; common causes are drugs such as minoxidil, phenytoin, and cyclosporine, along with congenital and paraneoplastic forms. Sort them with one sentence: whether androgen is involved, plus whether the site is androgen-dependent — hold onto these two keywords and you will never swap them. The whole chapter strings together into one line: the pilosebaceous unit has only three main axes — keratinization of sebum, miniaturization of the follicle, and occlusion of the follicle — follow the mechanism, and the treatment ladder arranges itself.

4. Where the Blister Splits: From Pemphigus to SJS, From Pathology to the ICU

🩺 At the bedside

A 68-year-old man has been breaking out in large blisters over his entire body for two weeks; the blister walls are tense and resist rupture, sitting on an itchy erythematous base, with no mucosal erosion. A 58-year-old woman is a different story altogether — oral ulcers have made eating too painful for three weeks, and her skin shows flaccid, easily ruptured blisters; the lightest push causes even the seemingly normal skin beside them to slough off as well, Nikolsky sign positive. The same week, the dermatology ICU admits a ten-year-old girl who, two weeks after starting carbamazepine, develops high fever, conjunctival erosion, eroded lips, and flaccid blisters rising beneath extensive truncal erythema — the epidermis peels away at the lightest push, and the denuded area is already approaching 35%.

The core of every question on blistering skin disease comes down to one sentence: at what level within the epidermis does the blister split — make that one cut, and the disease name, mechanism, and treatment nearly line themselves up on their own.

Three Anatomic Planes, Three Disease Families

🔬 Mechanism, unpacked

From the surface down, the epidermis is roughly divided into the stratum corneum, stratum spinosum, and stratum basale, with the basement membrane zone below the basal layer connecting it to the dermis. A blister can split at three levels: beneath the stratum corneum (superficial), within the epidermis above the basal layer, or beneath the epidermis (the basement membrane zone). The shallower the split, the thinner and more easily ruptured the blister (like the top layer of a Portuguese egg tart); the deeper the split, the tenser and more resistant to rupture the blister (like a water balloon). Hold onto this physical intuition, and you will understand why pemphigus vulgaris produces a thin blister with a positive Nikolsky sign, while bullous pemphigoid produces a tense blister with a negative Nikolsky sign.

Blister level	Mechanism	Representative disease
Subcorneal / superficial epidermis	Bacterial toxin or superficial cleavage	Impetigo, SSSS, pemphigus foliaceus
Intraepidermal (suprabasal)	Acantholysis	Pemphigus vulgaris (basal layer remains in a "tombstone" row)
Subepidermal (basement membrane zone)	Immune destruction of the basement membrane zone	Bullous pemphigoid, dermatitis herpetiformis (DH)

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

Autoimmune Blistering Disease: Immunofluorescence Is the Signature That Convicts

Disease	Autoantigen	Blister level	Immunofluorescence	Mucosa
Pemphigus vulgaris	Desmoglein 3 (± 1)	Intraepidermal (suprabasal)	Net-like intercellular IgG	Oral involvement common
Pemphigus foliaceus	Desmoglein 1	Subcorneal	Net-like intercellular IgG	Uncommon
Bullous pemphigoid	BP180 / BP230 (hemidesmosome)	Subepidermal (basement membrane zone)	Linear IgG / C3	Less common
Dermatitis herpetiformis (DH)	Epidermal transglutaminase	Dermal papillae	Granular IgA	—

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

Pathology Vocabulary: Lock In the Diagnosis From the Suffix

Term	Definition	Representative disease
Hyperkeratosis	Thickened stratum corneum	Chronic eczema, warts
Parakeratosis	Retained nuclei in the stratum corneum	Psoriasis
Acanthosis	Thickened stratum spinosum	Psoriasis, chronic dermatitis
Spongiosis	Intercellular epidermal edema	Acute eczema / contact dermatitis
Acantholysis	Loss of intercellular adhesion, cells detach	Pemphigus, Hailey-Hailey disease
Dyskeratosis	Premature, abnormal keratinization of individual cells	Darier disease, SCC

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

Parakeratosis should call psoriasis to mind, spongiosis should call eczema to mind, and acantholysis should call pemphigus to mind. Change one part of the word, and the diagnosis flips to its opposite — this is the trap pathology questions set most often: swapping parakeratosis with hyperkeratosis, or acanthosis with acantholysis.

Advanced Infiltrative Patterns

Interface dermatitis: inflammation concentrated at the epidermal-dermal junction, with basal vacuolar degeneration and necrotic keratinocytes → lupus erythematosus, lichen planus, graft-versus-host disease.
Lichenoid pattern: a band-like lymphocytic infiltrate hugging the epidermis in the superficial dermis → lichen planus (the classic saw-tooth rete ridges).
Granulomatous: tuberculosis, leprosy, sarcoidosis (a "naked" granuloma, without caseation).

Infectious Lesions: Can Live Organisms Be Cultured From It?

Disease	Can the pathogen be cultured from the lesion	Mechanism
Erythema migrans (Lyme disease)	Borrelia burgdorferi can be cultured	The spirochete spreads outward within the skin
Pityriasis rosea herald patch	No (HHV-6/7 suspected)	Viral, hard to culture
Erythema multiforme (EM)	No	Immune reaction to HSV and similar triggers
Erythema nodosum (EN)	No	Panniculitis, reactive

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

Erythema migrans ≠ erythema multiforme: the names look alike, but the former is a spirochete spreading in Lyme disease, and the latter is an immune reaction triggered by HSV. The exam loves nothing more than swapping these two terms.

The Full Spectrum of Drug Eruptions: From a Simple Rash to Full-Thickness Epidermal Death

🔬 Mechanism, unpacked

The causal chain of SJS/TEN:

① a drug or its metabolite acts as a hapten → ② it is presented by a particular HLA molecule to CD8+ cytotoxic T cells (which is exactly why the drug-HLA-ethnicity linkage matters so much) → ③ the T cells release granulysin, FasL, and perforin → ④ keratinocytes throughout the full thickness of the epidermis undergo apoptosis → ⑤ the epidermis separates from the dermis, resembling an extensive burn.

So "what percentage of BSA the dead epidermis covers" is the very core of grading and prognosis — denuded area↑ → fluid and electrolyte loss↑, loss of the infection barrier↑ → mortality↑. The mild end of the spectrum, a morbilliform rash, is only superficial inflammation and never reaches the point of apoptosis.

Classification	Epidermal detachment (% BSA)
SJS	< 10%
SJS/TEN overlap	10–30%
TEN	> 30%

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

Prognosis is scored with SCORTEN (7 items: age > 40, heart rate > 120, comorbid malignancy, BSA > 10%, BUN↑, glucose↑, HCO₃⁻↓).

The Four SCAR Siblings: Sorted by Speed and Blood Count

Disease	Mechanism	Latency	Features	Mucosa
SJS/TEN	Type IV cytotoxicity; granulysin / FasL / perforin	1–3 weeks	Full-thickness epidermal necrosis, blisters, Nikolsky positive	Severe involvement at ≥ 2 mucosal sites
DRESS	Eosinophilic + HHV-6 reactivation	2–6 weeks (slowest)	Fever, facial edema, eosinophilia, hepatitis/nephritis	Less common
AGEP	Neutrophilic, often β-lactams	< 2 days (fastest)	Sterile pustules, high fever, leukocytosis	Rare
Fixed drug eruption (FDE)	Local memory T cells	Hours to 2 days (on re-exposure)	Round, dusky-red patch recurring at the same site each time → post-inflammatory pigmentation	Lips/genitalia possible

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

AGEP is fastest, SJS/TEN intermediate, DRESS slowest — speed itself is a diagnostic clue. Seeing "sterile pustules erupting over the whole body within two days of starting a drug, with a leukocyte count that spikes" should make you think AGEP; "high fever, whole-face edema, eosinophilia, and soaring liver enzymes four weeks after starting a drug" should make you think DRESS.

Drug-HLA-Ethnicity: The Three Pairings the Han Chinese Population Must Remember

HLA	Drug	Outcome	Population
*HLA-B1502**	Carbamazepine	SJS/TEN	Han Chinese / Southeast Asian; screening required before treatment
HLA-B*5801	Allopurinol	SJS/TEN/DRESS	Han Chinese
HLA-B*5701	Abacavir	Hypersensitivity syndrome	Universal screening

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

Palmoplantar Erythema: Pick One of Three

Clue	Diagnosis
Cold symptoms/a new drug days earlier, target lesions, symmetric on the distal extremities	Erythema multiforme (EM) — pathology is interface dermatitis, not dermal fibrosis
Painless palmoplantar erythema, history of sexual contact, lymphadenopathy, generalized macular rash	Secondary syphilis — draw VDRL/RPR, TPPA
Recurs at the same site with the same drug every time	Fixed drug eruption

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

EM is mostly triggered by infection (HSV most common, Mycoplasma next), with drugs accounting for only a small share; SJS/TEN, in contrast, is overwhelmingly drug-induced. "Target lesions plus a history of infection" leans EM; "severe mucosal involvement plus epidermal detachment plus a recent new drug" leans SJS/TEN.

Management: Stop the Drug, Then Treat It Like a Burn

⭐ Board-exam essentials

Blistering Disease and Drug Eruptions · Must-Know Checklist

Three levels of blister split: subcorneal (SSSS, pemphigus foliaceus) / intraepidermal suprabasal (pemphigus vulgaris, acantholysis) / subepidermal basement membrane zone (bullous pemphigoid, DH); shallow and fragile vs. deep and tense.
Immunofluorescence as the conviction: pemphigus = net-like intercellular IgG (desmoglein 3); pemphigoid = linear IgG/C3 at the basement membrane (BP180/230); DH = granular IgA in the dermal papillae + celiac disease, treated with dapsone.
Parakeratosis = psoriasis; spongiosis = eczema; acantholysis = pemphigus; change one part of the word and the diagnosis flips.
Erythema migrans (Lyme disease) lesions yield Borrelia on culture; EM and EN are immune reactions and cannot be cultured; EM and erythema migrans sound alike but mean entirely different things.
BSA cutoffs: SJS < 10%, overlap 10–30%, TEN > 30%; SCORTEN scores prognosis.
Carbamazepine + HLA-B*1502 + Han Chinese → SJS/TEN, screening required before treatment; allopurinol pairs with HLA-B*5801; abacavir pairs with HLA-B*5701.
AGEP fastest, SJS/TEN intermediate, DRESS slowest; DRESS comes with eosinophilia + visceral involvement + HHV-6 reactivation.
Fixed drug eruption: recurs with the same drug at the same site every time, leaving post-inflammatory pigmentation.
Erythema multiforme pathology = interface dermatitis, not dermal fibrosis; linked to HSV, preventable with acyclovir.
SJS/TEN management = stop the drug + burn-style supportive care + ophthalmology consult; evidence growing for ciclosporin/etanercept, corticosteroids and IVIG remain controversial, avoid prophylactic antibiotics.
Palmoplantar erythema: think of three things: drug allergy / secondary syphilis / EM.
Sorafenib (a multikinase inhibitor) → hand-foot skin reaction + hair loss; EGFR inhibitors (cetuximab, erlotinib) → acneiform eruption.
Elevated IgE ≠ atopic dermatitis (not a diagnostic criterion).
Traps: flushing SJS/TEN with high-dose corticosteroids (controversial evidence), prophylactic systemic antibiotics (increase resistance); swapping erythema migrans with erythema multiforme; writing parakeratosis as hyperkeratosis or acantholysis as acanthosis; starting a Han Chinese patient on carbamazepine without first screening HLA-B*1502.

♪ Sing-along text — English rendering of the Mandarin song lyrics

🎵 Chapter song　皮膚・水疱在哪一層Spotify Apple Music

Alternate take (Version B): Spotify · Apple Music

Sung in Mandarin by Otter Whistle · album 《醫學國考・皮膚》 · the text below is an English rendering of the lyrics

A sixty-eight-year-old man has been breaking out in large blisters over his entire body for two weeks; the blister walls are tense and resist rupture, sitting on an itchy erythematous base, with no mucosal erosion. A fifty-eight-year-old woman is an entirely different story: oral ulcers have made eating too painful for three weeks, and her skin shows flaccid, easily ruptured blisters — the lightest push causes even the seemingly normal skin beside them to slough off as well, Nikolsky sign positive. The dermatology ICU has also admitted a ten-year-old girl who, two weeks after starting carbamazepine, developed high fever, conjunctival erosion, eroded lips, and flaccid blisters rising beneath truncal erythema, with denudation already approaching thirty-five percent — this is toxic epidermal necrolysis, with mortality running in the double digits. The core of every question on blistering skin disease really comes down to one sentence: at what level does the blister split — make that one cut, and the disease name, mechanism, and treatment nearly line themselves up on their own.

The shallower the blister, the thinner and easier it bursts; the deeper, the tenser and tougher it holds — the plane of the split writes its own name.

From the surface down, the epidermis has roughly a stratum corneum, a stratum spinosum, and a stratum basale, with the basement membrane zone below that connecting to the dermis. A blister can split at three levels. The first level, subcorneal and superficial epidermal, is where staphylococcal scalded skin syndrome, impetigo, and pemphigus foliaceus operate — because it is shallow, the blister wall is thin and ruptures extremely easily. The second level, intraepidermal above the basal layer, is where pemphigus vulgaris operates: the body makes its own IgG antibody against desmoglein 3 plus or minus 1, knocking out the desmosomal proteins between epidermal cells so the cells fall apart from one another — this is acantholysis — and immunofluorescence deposits a net-like pattern of IgG between the epidermal cells; the blister wall is thin, the Nikolsky sign is positive, mucosa is often affected first, and oral ulcers are the classic exam tell. The third level, subepidermal at the basement membrane zone, is where bullous pemphigoid operates: IgG against BP180 and BP230 strikes the hook joining epidermis to dermis, so the blister splits beneath the epidermis, the blister floor is dermis, the blister wall is tense and resists rupture, immunofluorescence shows a linear pattern of IgG and complement C3 along the basement membrane zone, and mucosa is less often affected. The signature of dermatitis herpetiformis is a granular deposit of IgA within the dermal papillae; it is almost always associated with celiac disease, so treatment has two arms — dapsone to control the skin, a gluten-free diet to control the source. Hold onto the four-word mnemonic: shallow and fragile is pemphigus, deep and tense is pemphigoid, and you will never mix up these two diseases separated by a single word.

The shallower the blister, the thinner and easier it bursts; the deeper, the tenser and tougher it holds — the plane of the split writes its own name.

Pathology vocabulary questions love nothing more than setting traps on the word ending. Parakeratosis is retained nuclei in the stratum corneum, incomplete keratinization, and stands for psoriasis; spongiosis is edema between epidermal cells, sponge-like, and stands for acute eczema and contact dermatitis; acantholysis is loss of adhesion between epidermal cells, with cells detaching, and stands for pemphigus. So never write parakeratosis as hyperkeratosis, or acantholysis as acanthosis — change one part of the word, and the diagnosis flips to its opposite. Among the inflammatory infiltrate patterns is also interface dermatitis, with inflammation concentrated at the epidermal-dermal junction, accompanied by basal vacuolar degeneration and necrotic keratinocytes, linking to lupus erythematosus, lichen planus, and graft-versus-host disease; lichen planus also shows a band-like lymphocytic infiltrate in the superficial dermis hugging the epidermis, producing saw-tooth rete ridges; a granulomatous infiltrate, meanwhile, corresponds to tuberculosis, leprosy, and the non-caseating granuloma of sarcoidosis.

Infection questions have another classic exam tell: whether a pathogen can be cultured from the lesion, and the answer hinges on whether live organisms are actually present in it. The erythema migrans of Lyme disease is the spirochete Borrelia burgdorferi spreading outward from the tick bite site, and live organisms sit right at the expanding erythema's edge, so it can be cultured. Conversely, erythema multiforme, erythema nodosum, and pityriasis rosea are all immune reactions or reactive panniculitis, with no live organism present in the lesion, so cultures come back negative. Be careful: erythema multiforme and erythema migrans sound almost identical but are entirely different diseases — the former is an immune reaction, the latter a spreading spirochete — never swap the two.

The shallower the blister, the thinner and easier it bursts; the deeper, the tenser and tougher it holds — the plane of the split writes its own name.

What is most worth thinking through in the drug-eruption spectrum is the physical meaning of severity. A drug or its metabolite acts as a hapten to trigger an immune response; at the mild end this is only superficial inflammation that shows up as a morbilliform rash, but the severe end — SJS and TEN — belongs to type IVc, T-cell-mediated cytotoxicity, in which cytotoxic T cells release granulysin, FasL, and perforin, driving keratinocytes throughout the full thickness of the epidermis into apoptosis and separating epidermis from dermis, much like an extensive burn — so what percentage of the body surface area the dead epidermis covers is the very core of grading and prognosis. SJS is under ten percent, overlap runs ten to thirty percent, and TEN is over thirty percent. The seven-item SCORTEN score includes age over forty, heart rate over one hundred twenty, comorbid malignancy, body surface area over ten percent, elevated BUN, elevated glucose, and decreased bicarbonate. The four siblings of severe cutaneous adverse reactions sort by speed: AGEP is fastest, erupting sterile pustules over the whole body within two days along with high fever and leukocytosis; SJS and TEN sit in the middle at one to three weeks; DRESS is slowest, taking two to six weeks to appear, and DRESS also comes with eosinophilia, hepatitis or nephritis, and reactivation of human herpesvirus 6 — this combination of slow onset, visceral involvement, and eosinophilia is its signature. Fixed drug eruption, meanwhile, recurs at the same site with the same drug every single time, leaving pigmentation behind after it heals.

Pharmacogenomics is a must-know topic on Taiwan's exam. Carbamazepine paired with HLA-B*1502 has a high carrier rate in Han Chinese and Southeast Asian populations and carries a high risk of SJS and TEN, so HLA-B*1502 must be screened for before starting the drug; allopurinol pairs with HLA-B*5801 in Han Chinese; abacavir pairs with HLA-B*5701, which is now screened for universally worldwide. Palmoplantar erythema should bring three things to mind: drug allergy, secondary syphilis, and erythema multiforme — syphilis must be confirmed by drawing VDRL and TPPA, so never overlook a history of sexual contact. The pathology of erythema multiforme is interface dermatitis, not dermal fibrosis — this is a wrong answer choice frequently used as a trap — and it is mainly triggered by infection, HSV being most common, so patients with recurrent episodes can be given acyclovir prophylaxis; SJS and TEN, in contrast, are overwhelmingly drug-induced. The most common and potentially fatal management error is treating SJS and TEN like an allergy and flushing them with high-dose corticosteroids; the core of management is actually to stop the drug immediately and provide burn-style supportive care — fluids and electrolytes, temperature, wound care, nutrition, and an ophthalmology consult are all required — while immunomodulation with ciclosporin and the anti-TNF agent etanercept has growing evidence for accelerating re-epithelialization, IVIG and systemic corticosteroids remain controversial, and prophylactic systemic antibiotics should be avoided to prevent resistance. The whole chapter strings together into a single principle: for blistering disease, look at what level the split occurs; for drug eruptions, look at how much epidermis has died — hold onto these two physical quantities, and diagnosis and treatment arrange themselves.

5. Red and Swollen, Itchy and Not: Urticaria, Angioedema, and Anaphylactic Shock

🩺 At the bedside

Three patients arrive at the emergency department, all "turning red all over." The first is a 24-year-old woman who ate shrimp ten minutes ago and is now covered in sharply demarcated, intensely itchy wheals, as if she had been bitten by mosquitoes from head to toe — but oddly, each wheal fades within 24 hours and leaves no trace. The second is a 55-year-old man on long-term lisinopril for hypertension, who wakes up in the early morning with his lips and tongue swollen like sausages, not itchy, and unresponsive to antihistamines. The third is an 8-year-old boy who, three minutes after his first-ever penicillin injection, develops full-body flushing, a hoarse voice, and a blood pressure that drops to 70/40 — this is anaphylaxis, and what saves his life is not an antihistamine but epinephrine.

The core of questions on redness and swelling comes down to two axes: is it itchy or not? And is the reaction driven by histamine or by bradykinin?

Urticaria: The Mast Cell Releases Histamine

A wheal resolves within 24 hours and leaves no trace; if a single wheal persists beyond 24 hours, is painful, and leaves bruising or pigmentation behind as it fades — that is not simple urticaria but urticarial vasculitis, which requires biopsy to confirm.

Category	Duration	Key points
Acute urticaria	< 6 weeks	Mostly related to infection, food, or drugs; often self-limited
Chronic urticaria (CU)	Persistent/recurrent ≥ 6 weeks	Mostly spontaneous (CSU); roughly half autoimmune (anti-FcεRI/IgE antibodies); may be a preceding/accompanying manifestation of autoimmune thyroid disease (Hashimoto's)

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

The Treatment Ladder for Chronic Urticaria

Step	Treatment
First line	Second-generation (non-sedating) antihistamine at standard dose (cetirizine, loratadine, etc.)
Second line	Increase the same drug's dose (up to 4× the standard dose)
Third line	Add omalizumab (anti-IgE)
Fourth line	Cyclosporine (CsA) or other immunomodulation

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

First line is a second-generation antihistamine, not cyclosporine (CsA); do not use long-term oral corticosteroids. Corticosteroids are reserved for short-term (days-long) rescue during a severe acute flare — used long-term, they carry heavy side effects and do not alter the disease course.

Angioedema's Three Stories: Itchy or Not, With or Without Urticaria

Type	Urticaria	Itch	Antihistamines	Management
Histaminergic/allergic	Present	Present	Effective	Antihistamines, epinephrine
ACEI-induced	Absent	Absent	Ineffective	Stop the ACEI
HAE	Absent	Absent	Ineffective	C1-INH replacement; C4 low

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

Penicillin Allergy and Anaphylaxis: There Is Only One Lifesaving Move

⭐ Board-exam essentials

Urticaria, Angioedema, and Anaphylactic Shock · Must-Know Checklist

Chronic urticaria is defined as ≥ 6 weeks (the trap writes 4 weeks).
First line = second-generation antihistamine; do not use long-term oral corticosteroids; cyclosporine (CsA) is a later-line agent.
CSU can be a preceding manifestation of autoimmune thyroid disease (Hashimoto's); screen recurrent cases with anti-TPO.
A wheal resolves within 24 hours and leaves no trace; if > 24 hours, painful, and leaves a trace → urticarial vasculitis (biopsy required).
Three types of angioedema: allergic (urticaria present, antihistamines effective) / ACEI (bradykinin) (no urticaria, antihistamines ineffective, stop the drug) / HAE (C1-INH deficient, C4 low).
Penicillin allergy: fatal anaphylaxis can still occur on the very first exposure (no prior allergy history is no guarantee of safety).
First line for anaphylaxis = IM adrenaline; antihistamines and corticosteroids are adjuncts only.
Itch plus a wheal = histamine type; swelling alone with no itch, unresponsive to antihistamines = bradykinin type (ACEI / HAE).
Traps: writing the CSU definition as 4 weeks (should be ≥ 6 weeks); writing first line as cyclosporine or long-term oral corticosteroids; continuing to add antihistamines for ACEI-induced angioedema (should stop the ACEI instead); giving corticosteroids/antihistamines for HAE (ineffective — needs C1-INH); assuming safety just because there is no prior history of penicillin allergy.

♪ Sing-along text — English rendering of the Mandarin song lyrics

🎵 Chapter song　皮膚・紅與腫、癢與不癢Spotify Apple Music

Alternate take (Version B): Spotify · Apple Music

Sung in Mandarin by Otter Whistle · album 《醫學國考・皮膚》 · the text below is an English rendering of the lyrics

The emergency department receives three patients turning red all over, one after another. The first is a twenty-four-year-old woman who, ten minutes after eating shrimp, breaks out all over in sharply demarcated, intensely itchy wheals, though each one fades within twenty-four hours and leaves no trace. The second is a fifty-five-year-old man on long-term lisinopril for blood pressure control, who wakes in the early morning with his lips and tongue swollen like sausages, not itchy, unresponsive to antihistamines. The third is an eight-year-old boy who, three minutes after his first penicillin injection, develops full-body flushing, a hoarse voice, and a blood pressure that drops to seventy over forty — this is anaphylactic shock, and the lifesaving move is neither an antihistamine nor a corticosteroid, but an intramuscular injection of epinephrine. Questions on redness and swelling sort along only two axes: itchy or not, and whether the reaction is driven by histamine or by bradykinin.

Itch plus a wheal means histamine; swelling alone that antihistamines can't touch means think bradykinin.

The essential nature of urticaria is mast cell degranulation releasing histamine, causing superficial dermal vessels to dilate and leak and forming a wheal — itchy, sharply demarcated, each individual lesion resolving within twenty-four hours and leaving no trace. If the edema extends deep into the dermis or subcutis, that is angioedema, favoring the eyelids, lips, tongue, and larynx, presenting mainly as swelling and tightness rather than itch. Two frequently tested traps are worth separating clearly. First, if a single wheal persists beyond twenty-four hours, is painful and burning, and leaves bruising or pigmentation behind as it fades, think urticarial vasculitis, a leukocytoclastic vasculitis that requires biopsy to confirm — not simple urticaria. Second, chronic urticaria is defined as symptoms persisting or recurring for six weeks or more, not four weeks, and this number is tested every single year. Chronic urticaria is mostly spontaneous, with roughly half carrying an autoimmune mechanism in which the body produces antibodies against the high-affinity IgE receptor or against IgE itself, which is why it often coexists with autoimmune thyroid disease, and recurrent cases can be screened with anti-TPO and thyroid function tests. The treatment ladder runs with a first line that must be a second-generation, non-sedating antihistamine at standard dose; a second line of increasing the same drug up to four times the standard dose; a third line of adding omalizumab, an anti-IgE monoclonal antibody; and a fourth line of cyclosporine (CsA) or other immunomodulation. The most commonly reversed trap is writing the first line as cyclosporine (CsA) or long-term oral corticosteroids — both wrong, since corticosteroids can only serve as short-term rescue and do not alter the disease course.

Itch plus a wheal means histamine; swelling alone that antihistamines can't touch means think bradykinin.

The key to differentiating angioedema is whether the dominant mediator is histamine or bradykinin. Histaminergic or allergic angioedema comes with urticaria, is itchy, and responds to both antihistamines and epinephrine; angioedema caused by an angiotensin-converting enzyme inhibitor is entirely different — this class of drug inhibits the very enzyme that breaks down bradykinin, so bradykinin accumulates and the tissue swells, meaning there is no accompanying urticaria and no itch, antihistamines can't touch it, and the drug must be stopped immediately rather than escalating the dose. Hereditary angioedema, meanwhile, involves C1 inhibitor deficiency with low complement C4, no accompanying urticaria, and a positive family history; corticosteroids and antihistamines are both useless, and treatment requires C1 inhibitor replacement, a bradykinin receptor antagonist, or a kallikrein inhibitor. So for that man whose lips and tongue were swollen like sausages with no itch, check his medication history first — if he has been on long-term lisinopril or enalapril, the ACEI must be stopped rather than adding yet more antihistamine. One mnemonic is enough: itch plus a wheal is histamine type; swelling alone with no itch, unresponsive to antihistamines, means think bradykinin, and from there sort out whether it is drug-induced or hereditary.

Itch plus a wheal means histamine; swelling alone that antihistamines can't touch means think bradykinin.

Last comes penicillin allergy and anaphylactic shock. The most dangerous misconception is assuming that never having had it before means you can't be allergic. Penicillin allergy is an IgE-mediated, immediate-type hypersensitivity; the body may already have been sensitized through environmental exposure or contact with structurally similar compounds, so fatal anaphylactic shock can erupt on the very first clinical dose — meaning no history of allergy is no guarantee of safety. There is only one lifesaving move for treating anaphylactic shock: an intramuscular injection of epinephrine into the lateral thigh, with antihistamines and corticosteroids serving only as adjuncts — they are not what saves the patient's life. The whole chapter distills into one line: when you see redness and swelling, first ask whether it itches, then ask whether it is a wheal or deep edema, then look at the dominant mediator — the histamine type calls for antihistamines and epinephrine, the bradykinin type always calls for stopping the drug or replacing C1 inhibitor first, and saving a patient from anaphylactic shock always means giving epinephrine first, before anything else.

6. Genes and Pigment: The Skin's Wall, Part by Part

🩺 At the bedside

A newborn girl is admitted to the neonatal intensive care unit encased head to toe in thick, armor-like plates of keratin, as if clad in a full suit of armor, with deep fissures carving the skin into diamond-shaped plaques, ectropion of the eyelids and eclabium of the lips, rapid breathing, and an unstable body temperature — this is Harlequin ichthyosis, caused by a defect in ABCA12, the transporter protein responsible for carrying lipids into the stratum corneum. That same week in clinic, a 22-year-old man flares every summer with greasy, crusted, foul-smelling keratotic papules across his chest and back, and nails showing V-shaped notches with red-and-white longitudinal streaks — this is Darier disease. In the next bed, a 60-year-old woman has symmetric brown patches across both cheeks, the forehead, and the upper lip that darken during pregnancy — melasma.

The exam questions on inherited skin disease and pigmentary disorders boil down to one sentence: whichever component the gene breaks is the layer where the skin fails; for pigment, ask whether it is "gone" or "too much," and whether the cell has "vanished" or merely "malfunctioned."

Ichthyosis: A Broken Barrier

🔬 Mechanism, unpacked

The stratum corneum can block water and pathogens because it is a brick wall built from corneocytes (the bricks) plus intercellular lipids (the mortar). Whichever component fails is the layer where the skin fails — this is the master causal logic behind every ichthyosis:

① Filaggrin fails (ichthyosis vulgaris, the most common form) → the intercellular "mortar" loosens → corneocytes no longer adhere tightly → dry skin, a defective barrier → allergens penetrate easily, bringing atopic dermatitis along with it.

② Steroid sulfatase deficiency (X-linked, males) → the placenta shares the same enzyme deficiency → the mother's labor is delayed → after birth, cholesterol sulfate accumulates, producing large, dark scales.

③ TGM1 mutation (lamellar ichthyosis / CIE) → corneocytes cannot cross-link → the infant is born a collodion baby.

④ ABCA12 mutation (the most severe) → lipids cannot be transported to the stratum corneum → the stratum corneum is left lipid-free → the barrier collapses completely → thick, armor-like plates cover the entire body with ectropion and eclabium — this is Harlequin ichthyosis.

Type	Inheritance / gene	Key features
Ichthyosis vulgaris (most common)	AD, filaggrin (FLG)	Fine scale on extensor surfaces, increased palmar markings, frequently coexists with atopic dermatitis
X-linked ichthyosis	XR, steroid sulfatase (STS) deficiency	Males; large, dark scales; maternal labor may be delayed (placental sulfatase deficiency)
Lamellar / CIE	AR, TGM1 (transglutaminase-1)	Born a collodion baby
Harlequin ichthyosis	AR, ABCA12	The most severe: born with thick, plate-like armor, deep fissures, ectropion / eclabium

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

Darier Disease and EB: Calcium Pumps and Structural Proteins

Subtype	Cleavage plane	Defective protein	Inheritance	Severity
EB simplex (EBS)	Intraepidermal (basal keratinocyte)	Keratin 5 / 14	Mostly AD	Milder, heals without scarring
Junctional (JEB)	Lamina lucida	Laminin-332, collagen XVII	AR	Severe; the Herlitz type can be fatal
Dystrophic (DEB)	Sub-lamina densa	Collagen VII (anchoring fibrils)	AD/AR	Heals with scarring, mitten-hand fusion of the digits, esophageal strictures, ↑SCC risk

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

Diagnosis relies on immunofluorescence antigen mapping / transmission electron microscopy to determine the cleavage plane and the missing protein; genetic testing confirms it. There is no cure — management is supportive: wound care, friction avoidance, infection prevention, nutritional support, and surveillance for complications (anemia, strictures, skin cancer).

Two Directions for Pigment: Loss or Excess

🔬 Mechanism, unpacked

The key to pigmentary disease is two axes: (1) is pigment deficient or excessive? (2) are melanocytes gone/destroyed, or present but functioning abnormally?

The melanin synthesis pathway: tyrosine → (tyrosinase) → DOPA → melanin, synthesized inside the melanosome and then transferred to keratinocytes. Three disease pathways branch off it in different directions:

① Albinism (OCA): a defective gene such as tyrosinase (AR) → synthesis inside the melanosome halts → the cell count is normal, but it cannot make pigment → generalized depigmentation, nystagmus, photophobia.

② Vitiligo: autoimmunity (CD8+ T cells) recognizes melanocyte antigens → melanocytes are wiped out → the cells "vanish" (destroyed) → sharply demarcated milky-white patches that enhance under Wood's lamp; because it shares the same autoimmune predisposition, it frequently coexists with Hashimoto thyroiditis, T1DM, and pernicious anemia.

③ Melasma: ultraviolet light + female hormones (pregnancy, oral contraceptives) + genetics → melanocytes become overactive (normal in number) → symmetric brown patches on the cheekbones/forehead/upper lip.

Disease	Melanocyte status	Mechanism	Key features
Vitiligo	Completely absent (destroyed)	Autoimmune destruction	Sharply demarcated milky-white patches, enhance under Wood's lamp; frequently coexists with autoimmune thyroid disease, T1DM, pernicious anemia
Chemical leukoderma	Absent/damaged	Chemical toxicity	Exposure to phenol / hydroquinone derivatives / 4-tertiary butyl catechol / monobenzone; occupational, rubber gloves
Albinism (OCA)	Normal in number, nonfunctional	Defective gene such as tyrosinase (AR)	Generalized, present from birth, nystagmus, photophobia
Pityriasis alba	Normal	Postinflammatory hypopigmentation (often atopic)	Fine, pale scale on the face, reversible
Tinea versicolor	Normal	Malassezia produces azelaic acid, which inhibits tyrosinase	KOH shows "spaghetti and meatballs" hyphae and spores; pigment returns after treatment

Swipe or scroll sideways to compare every column; keyboard: focus the table and use arrow keys.

Vitiligo = cells "vanish"; albinism = cells are "present but cannot make pigment"; melasma = cells are "present and overactive." Hold onto these three sentences and most pigmentary-disease questions sort themselves out.

Repigmentation in Vitiligo: Small Dark Dots Centered on the Follicle

Treatment: topical calcineurin inhibitors / corticosteroids, narrowband UVB (NB-UVB) phototherapy, and JAK inhibitors for severe cases; epidermal grafting is an option once disease is stable.

Melasma: Inhibit the Enzyme, Block the Sun

⭐ Board-exam essentials

Genetic Structure and Pigment — Must-Know Checklist

Ichthyosis vulgaris ↔ filaggrin ↔ coexists with atopic dermatitis; X-linked ↔ steroid sulfatase (males, maternal labor may be delayed); Lamellar/CIE ↔ TGM1 (collodion baby); Harlequin ↔ ABCA12, the most severe, ectropion/eclabium.
Darier: ATP2A2/SERCA2, acantholysis plus dyskeratosis, corps ronds/grains, V-shaped nail notches; worsens with summer/heat/sweat/sun (not winter); contrast with Hailey-Hailey = ATP2C1/SPCA1, flexural sites, no dyskeratosis.
EB is a genetic disease, not autoimmune; treatment is supportive only; EBS intraepidermal (K5/14) / JEB junctional (laminin-332) / DEB superficial dermal (collagen VII — scarring, mitten-hand fusion of the digits, esophageal strictures, ↑SCC).
Vitiligo = melanocytes autoimmune-destroyed and "gone" (not merely reduced function); enhances under Wood's lamp; frequently coexists with autoimmune thyroid disease, T1DM, pernicious anemia.
Follicular repigmentation after phototherapy for vitiligo draws pigment from the outer-root-sheath reservoir; repigmentation is poor in hairless areas.
Chemical leukoderma: occupational exposure to phenol / hydroquinone derivatives / monobenzone / 4-TBC; the key treatment is removing the source of exposure.
Albinism: tyrosinase deficiency, normal cell number but unable to produce pigment (distinguish from vitiligo's "cells vanish").
Melasma = ↑melanocyte activity (normal cell number), driven by UV + hormones; mainstay = sun protection + topical hydroquinone (inhibits tyrosinase); laser easily darkens and comes last.
Reversible pigment changes: pityriasis alba, tinea versicolor (Malassezia produces azelaic acid, inhibiting tyrosinase) — pigment returns after treatment; do not mistake these for permanent depigmentation.
Traps: describing vitiligo as "reduced cell function" (it is actually cell loss); describing melasma as an increase in melanocyte number (it is actually increased activity); treating melasma with laser first-line (easily darkens); calling Darier a winter-worsening disease (it is summer); mistaking EB for an autoimmune blistering disease; confusing the collodion baby with Harlequin (the latter is more severe and molecularly ABCA12).

♪ Sing-along text — English rendering of the Mandarin song lyrics

🎵 Chapter song　皮膚・基因與色素Spotify Apple Music

Alternate take (Version B): Spotify · Apple Music

Sung in Mandarin by Otter Whistle · album 《醫學國考・皮膚》 · the text below is an English rendering of the lyrics

A newborn girl is admitted to the neonatal intensive care unit, her entire body covered in thick, armor-like plates of keratin, deep fissures carving her skin into diamond shapes, both eyelids and lips turned outward, her barrier collapsed, breathing rapid, temperature swinging — this is Harlequin ichthyosis, the gene broken being ABCA12, the transporter responsible for carrying lipids to the stratum corneum. That same week, a twenty-two-year-old man flares in summer, greasy, crusted, foul-smelling keratotic papules erupting across his chest and back, his nails carrying V-shaped notches plus red-and-white streaks — this is Darier disease. In the next bed, a sixty-year-old woman has symmetric brown patches on both cheeks, forehead, and upper lip, darkening in pregnancy — this is melasma. The core of every exam question on inherited skin disease and pigmentary disorders is one sentence: whichever component the gene breaks is the layer where the skin fails; for pigment, ask whether it is gone or in excess, and whether the cell has vanished or merely stopped working.

Whichever component the gene breaks, that is the layer where the skin fails — for pigment disease, ask again whether the cell is gone or still there.

Ichthyosis tests a broken barrier. The stratum corneum blocks water and pathogens because of this brick wall built from corneocytes plus intercellular lipids. Whichever component fails is the layer where the skin fails. When filaggrin fails, the mortar between corneocytes loosens, the skin turns dry, the barrier fails, and atopic dermatitis comes along with it, because filaggrin is itself an atopy risk gene — which is why the most common form, ichthyosis vulgaris, shares the same gene with atopic dermatitis. X-linked ichthyosis is a steroid sulfatase deficiency, striking males, producing large dark scales, and because the placenta shares the same enzyme, the mother's labor may be delayed at delivery. Lamellar ichthyosis and congenital ichthyosiform erythroderma come from a broken TGM1, presenting at birth as a collodion baby. The most severe is Harlequin, where ABCA12 fails, the stratum corneum is left without lipid, the barrier collapses, and the infant develops thick, armor-like plates with deep fissures and ectropion of the eyelids and lips — historically often fatal. Do not write the collodion baby as Harlequin; the latter is more severe, and its molecule is ABCA12.

Whichever component the gene breaks, that is the layer where the skin fails — for pigment disease, ask again whether the cell is gone or still there.

Darier disease follows a different path. It arises from an ATP2A2 mutation encoding SERCA2, the endoplasmic reticulum's calcium pump; once calcium signaling is disrupted, desmosome assembly fails, keratinocytes lose their adhesion, and histology shows acantholysis plus dyskeratosis, along with the pathognomonic corps ronds and grains. The most commonly tested reversal is its timing of flares: most ichthyoses fear dryness and worsen in winter, but Darier instead fears heat, sweat, sun exposure, and friction, so it worsens in summer — remember it fears heat, not dryness, and you will never miss this. Its exam partner is Hailey-Hailey disease, whose gene is ATP2C1, encoding the Golgi calcium pump SPCA1; both are autosomal dominant, and both cause acantholysis through a broken calcium pump, but Hailey-Hailey favors the flexures and typically shows neither dyskeratosis nor corps ronds and grains, which is how the two are distinguished.

Water-blister diseases need one more mention. Epidermolysis bullosa's core fact is that it is a genetic disease, not autoimmune — completely different in nature from the autoimmune blistering of pemphigus and pemphigoid — and treatment is supportive only, with no cure. Minor mechanical friction triggers blistering, subtypes are defined by which layer splits, and the deeper the cleavage, the worse the scarring. The simplex type splits within the epidermis, at the basal keratinocyte, with a defect in keratin 5 or 14, mostly autosomal dominant, healing without scarring; the junctional type splits at the lamina lucida, with a defect in laminin-332 or collagen XVII, autosomal recessive, and the severe Herlitz type can be fatal; the dystrophic type splits below the lamina densa, with a defect in collagen VII — the anchoring fibrils — either dominant or recessive, healing with scarring, mitten-hand fusion of the digits, esophageal strictures, and an elevated risk of squamous cell carcinoma. Diagnosis relies on immunofluorescence antigen mapping or transmission electron microscopy to see the cleavage plane and the missing protein, with genetic testing to confirm.

Whichever component the gene breaks, that is the layer where the skin fails — for pigment disease, ask again whether the cell is gone or still there.

Pigmentary disease has only two exam axes: whether pigment is deficient or excessive, and whether the cell has vanished or is still there. Melanin synthesis proceeds as tyrosine is catalyzed by tyrosinase into DOPA and then into melanin, synthesized inside the melanosome and then transferred to keratinocytes. A break at any step produces an abnormality of pigment. An enzyme deficiency, such as a defective tyrosinase gene, gives albinism — the cell count is normal but cannot make pigment, so it is present from birth, generalized, with nystagmus and photophobia. Cells destroyed and gone give vitiligo, where autoimmunity wipes out melanocytes, producing sharply demarcated milky-white patches that enhance under Wood's lamp, frequently coexisting with autoimmune thyroid disease, type 1 diabetes, and pernicious anemia — which is exactly why it favors this group of patients. Describing vitiligo as reduced melanocyte function is wrong; the cells are destroyed and gone, so remember vanished, not merely disabled. Chemical leukoderma instead comes from occupational chemical exposure — phenol, hydroquinone derivatives, monobenzone, and 4-TBC — poisoning melanocytes, and the key to treatment is removing the source of exposure. Pityriasis alba is fine, depigmented scale on the face of atopic children, a reversible postinflammatory hypopigmentation — never treat it as permanent depigmentation; tinea versicolor, meanwhile, comes from Malassezia producing azelaic acid that inhibits tyrosinase, which is reversible and repigments after treatment.

The mechanism of repigmentation in vitiligo is a small must-know highlight. After phototherapy, small dark dots centered on the hair follicles appear; the pigment comes from the melanocyte precursor reservoir in the outer root sheath, awakened by phototherapy and migrating outward from the follicle — which is why hairless regions such as the fingertips and lips repigment worst, since there is no reservoir to draw from. Treatment includes topical calcineurin inhibitors or corticosteroids, narrowband UVB phototherapy, JAK inhibitors for severe cases, and epidermal grafting once the disease is stable. Melasma, finally, runs in the opposite direction — melanocyte activity is excessive rather than cell number increased — driven by ultraviolet light, female hormones, and genetics, so it appears symmetrically on the cheekbones, forehead, and upper lip, worsening during pregnancy or with oral contraceptives. Treatment addresses these three drivers in turn: strict sun protection is the cornerstone, topical hydroquinone to inhibit tyrosinase is the classic first choice, and Kligman's triple combination plus azelaic acid and tranexamic acid follow for refractory cases, while laser easily causes post-inflammatory darkening and relapse and is reserved for last, used with caution. The whole chapter comes down to one mantra: whichever component the gene breaks decides which layer of the skin fails; for pigmentary disease, first check whether pigment is deficient or excessive, then check whether the cell is still there — follow the mechanism, and the diagnosis surfaces on its own.

Conclusion: The Skin as a Dashboard

Starting from the cellular origins of the epidermis's three great lineages, we have moved through the skin as a window onto systemic disease, the disorders of the hair follicle and sebaceous unit, the immune mechanisms behind blisters and inflammation, and on to the survival or loss of cells at the level of genes and pigment. Having read this entire volume on the skin, you will find it has really been saying only one thing — the skin is the dashboard the body wears on the outside: every color, every scale, every blister speaks on behalf of a deeper organ system.

Distill this book into three sentences. First, when you see a lesion, ask about its cell of origin — basal cells are slow and steady, keratinocytes migrate to lymph nodes, melanocytes wander far from home; spongiosis in the epidermis means eczema that will weep, epidermal hyperplasia means psoriasis that is dry, silvery, and thick; anything that accumulates in the dermis turns it asymptomatically firm, with diabetes depositing mucopolysaccharide, sarcoidosis forming granulomas, and scleroderma laying down fibrosis, each with its own starting point. Second, when you see blisters or inflammation, ask about the plane and the mediator — the shallower and thinner a blister, the more easily it ruptures, while the deeper and tenser it is, the more it resists rupture; a fishnet, linear, or granular pattern on immunofluorescence points respectively to pemphigus, pemphigoid, or dermatitis herpetiformis; for redness and swelling, first ask whether it itches — itching plus wheals means a histamine-driven process, while swelling without itching that fails to respond to antihistamines should make you think of bradykinin; for a drug eruption, judge by how much epidermis has died — AGEP is fastest, SJS/TEN intermediate, DRESS slowest — and carbamazepine must always be screened against HLA-B 1502 before prescribing in patients of Han Chinese descent. Third, when you see a genetic or pigmentary finding, ask which component is broken and whether the cell is still there — a broken filaggrin ruins the barrier, a broken ABCA12 builds a suit of armor, Darier fears heat rather than dryness, EB is genetic rather than autoimmune; vitiligo is disappearance, albinism is disability, melasma is overactivity — and treatment must always match the mechanism behind it, never the symptom itself.

What truly earns you steady points on the exam is never memorizing these tables by rote, but grasping the causal chain behind every section: reasoning from morphology to mechanism, from mechanism to diagnosis, from diagnosis to treatment. Once you can look at an unfamiliar photograph of skin and work backward to "which component, in which layer, has gone wrong," the skin stops being a thousand disease names and becomes a dashboard you know how to read. May this dashboard carry you through the exam hall, and walk with you into every real clinic you enter afterward.